The Effect of Motivational Interview on Hemodialysis Patients

Status Enrolling by invitation

Clinical Trial Summary

This research consists of two stages: the first stage aims to evaluate the validity and reliability of the Hemodialysis Resilience Scale, which was developed to evaluate the resilience of patients receiving hemodialysis treatment, in Turkish society, and the second stage aims to determine the effect of motivational interviewing method on patients' psychological resilience and compliance with hemodialysis treatment in individuals undergoing hemodialysis. The main question it aims to answer is: Does motivational interviewing has an effect on psychological resilience and treatment compliance of hemodialysis patients?

Clinical Trial Description

The aims of this study are to evaluate the validity and reliability of the Hemodialysis Resilience Scale, which was developed to evaluate the resilience of patients receiving hemodialysis treatment, in Turkish society, and to determine the effect of motivational interviewing method on patients' psychological resilience and compliance with hemodialysis treatment in individuals undergoing hemodialysis. This research consists of two stages: the first stage is a methodological study for scale adaptation, and second stage is randomized, controlled, and single blinded study for determining the effect of motivational interviewing. The first stage is carried out in patients undergoing hemodialysis in two different hospitals. The second stage of the study consists of a randomized, controlled, and single-blinded experimental study to determine the effect of motivational interviewing on individuals undergoing hemodialysis treatment, in terms of psychological resilience and compliance with treatment. The "simple randomization method" was chosenfor allocation in order to provide an equal number of samples in the two groups. In order to reduce the selection bias in determining intervention and control groups, a list was created by a third party (dialysis center nurse) who did not have a direct role in the study, and assignments were performed using the random numbers table. The intervention and control group patients were scheduled to have hemodialysis sessions on different days. In the study, blinding was applied only to the patient groups because the groups were known by the researchers and nurses. ;

Study Design

Related Conditions & MeSH terms

Hemodialysis

Clinical Trial Details

NCT number	NCT05671536
Study type	Interventional
Source	Baskent University
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	April 26, 2022
Completion date	March 25, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04892745` - Impact of Hemodialysis on Cutaneo-muscular Electrical Impedance
Not yet recruiting	`NCT04925674` - Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.	Phase 1
Active, not recruiting	`NCT03183245` - Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis	Phase 3
Completed	`NCT03365635` - Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C	Phase 4
Withdrawn	`NCT02904343` - Evaluation of Domestic Hemodialysis Machine: A Multi-center Clinical Study	N/A
Withdrawn	`NCT01855334` - L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD	Phase 4
Completed	`NCT01700465` - Estimating and Predicting Hemodynamic Changes During Hemodialysis	N/A
Recruiting	`NCT01195519` - The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis	N/A
Completed	`NCT00737672` - GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis	Phase 3
Completed	`NCT00527774` - Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients	N/A
Completed	`NCT00942253` - Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)	Phase 2
Completed	`NCT00850252` - Use of a Lifeline Graft in the A-V Shunt Model	Phase 1/Phase 2
Completed	`NCT00224081` - DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)	Phase 4
Completed	`NCT00776750` - Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients	Phase 4
Recruiting	`NCT06351007` - Educational Program on Dietary Adherence and Nutritional Knowledge in Chronic Kidney Disease Patients (EPAK)	N/A
Withdrawn	`NCT03664141` - Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study)	Phase 3
Completed	`NCT03909698` - Antibiotic Dosing in Patients on Intermittent Hemodialysis
Recruiting	`NCT03311321` - Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients	N/A
Recruiting	`NCT06098924` - HD Patients' Depression and Happiness
Recruiting	`NCT03419923` - Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.